These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 7617651)
1. Expression of tumor-associated glycoprotein 72 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. Myers RB; Schlom J; Srivastava S; Grizzle WE Mod Pathol; 1995 Apr; 8(3):260-5. PubMed ID: 7617651 [TBL] [Abstract][Full Text] [Related]
2. Reduced 15-lipoxygenase-2 immunostaining in prostate adenocarcinoma: correlation with grade and expression in high-grade prostatic intraepithelial neoplasia. Jack GS; Brash AR; Olson SJ; Manning S; Coffey CS; Smith JA; Shappell SB Hum Pathol; 2000 Sep; 31(9):1146-54. PubMed ID: 11014584 [TBL] [Abstract][Full Text] [Related]
3. Lewis Y antigen as detected by the monoclonal antibody BR96 is expressed strongly in prostatic adenocarcinoma. Myers RB; Srivastava S; Grizzle WE J Urol; 1995 May; 153(5):1572-4. PubMed ID: 7714977 [TBL] [Abstract][Full Text] [Related]
5. Expression of p160erbB-3 and p185erbB-2 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. Myers RB; Srivastava S; Oelschlager DK; Grizzle WE J Natl Cancer Inst; 1994 Aug; 86(15):1140-5. PubMed ID: 7913137 [TBL] [Abstract][Full Text] [Related]
6. Applications of monoclonal antibodies in clinical cytology as exemplified by studies with monoclonal antibody B72.3. The George N. Papanicolaou award lecture. Johnston WW Acta Cytol; 1987; 31(5):537-56. PubMed ID: 3314301 [TBL] [Abstract][Full Text] [Related]
7. Amphiregulin expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 93 cases. Bostwick DG; Qian J; Maihle NJ Prostate; 2004 Feb; 58(2):164-8. PubMed ID: 14716741 [TBL] [Abstract][Full Text] [Related]
9. STEAP1 is overexpressed in prostate cancer and prostatic intraepithelial neoplasia lesions, and it is positively associated with Gleason score. Gomes IM; Arinto P; Lopes C; Santos CR; Maia CJ Urol Oncol; 2014 Jan; 32(1):53.e23-9. PubMed ID: 24239460 [TBL] [Abstract][Full Text] [Related]
10. High-grade foamy gland prostatic adenocarcinoma on biopsy or transurethral resection: a morphologic study of 55 cases. Zhao J; Epstein JI Am J Surg Pathol; 2009 Apr; 33(4):583-90. PubMed ID: 19033862 [TBL] [Abstract][Full Text] [Related]
11. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases. Tavora F; Epstein JI Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of retinoblastoma and p53 tumor suppressor genes in prostatic intraepithelial neoplasia: comparison with prostatic adenocarcinoma and benign prostate. Tamboli P; Amin MB; Xu HJ; Linden MD Mod Pathol; 1998 Mar; 11(3):247-52. PubMed ID: 9521470 [TBL] [Abstract][Full Text] [Related]
13. Expression of tumor-associated glycoprotein-72 (TAG-72) antigen in human prostatic adenocarcinomas. Karan D; Johansson SL; Lin MF; Batra SK Oncol Rep; 2001; 8(5):1123-6. PubMed ID: 11496328 [TBL] [Abstract][Full Text] [Related]
14. TAG-72 expression in primary, metastatic and hormonally treated prostate cancer as defined by monoclonal antibody CC49. Brenner PC; Rettig WJ; Sanz-Moncasi MP; Reuter V; Aprikian A; Old LJ; Fair WR; Garin-Chesa P J Urol; 1995 May; 153(5):1575-9. PubMed ID: 7536270 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissue. Hobisch A; Rogatsch H; Hittmair A; Fuchs D; Bartsch G; Klocker H; Bartsch G; Culig Z J Pathol; 2000 Jul; 191(3):239-44. PubMed ID: 10878544 [TBL] [Abstract][Full Text] [Related]
16. Pathological parameters of radical prostatectomy for clinical stages T1c versus T2 prostate adenocarcinoma: decreased pathological stage and increased detection of transition zone tumors. Jack GS; Cookson MS; Coffey CS; Vader V; Roberts RL; Chang SS; Smith JA; Shappell SB J Urol; 2002 Aug; 168(2):519-24. PubMed ID: 12131301 [TBL] [Abstract][Full Text] [Related]
17. Expression of a novel biomarker, EPCA, in adenocarcinomas and precancerous lesions in the prostate. Uetsuki H; Tsunemori H; Taoka R; Haba R; Ishikawa M; Kakehi Y J Urol; 2005 Aug; 174(2):514-8. PubMed ID: 16006883 [TBL] [Abstract][Full Text] [Related]
19. Ki-67 antigen and P53 protein expression in benign and malignant prostatic lesions. Immunohistochemical quantitative study. Sasor A; Wagrowska-Danilewicz M; Danilewicz M Pol J Pathol; 2000; 51(1):31-6. PubMed ID: 10833901 [TBL] [Abstract][Full Text] [Related]
20. Heat shock protein expression independently predicts clinical outcome in prostate cancer. Cornford PA; Dodson AR; Parsons KF; Desmond AD; Woolfenden A; Fordham M; Neoptolemos JP; Ke Y; Foster CS Cancer Res; 2000 Dec; 60(24):7099-105. PubMed ID: 11156417 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]